Polio

Research-Giant Salk Institute Taps Into Web3’s Largest Workforce

Retrieved on: 
Sunday, December 18, 2022
Salk Institute for Biological Studies, Animal, HMT, Map, Polio, Ecosystem, Web3, Algorithm, Operation, Human, Machine learning, Protocol, Workforce, Plant, NIH, Ageing, Research, Brain, Partnership, Management, Cryptocurrency, Pharmaceutical industry, Jonas Salk

“By coming together with a scientific juggernaut like Salk Institute, we are looking to foster various research opportunities.

Key Points: 
  • “By coming together with a scientific juggernaut like Salk Institute, we are looking to foster various research opportunities.
  • HUMAN protocol’s decentralized workforce will help the Salk Institute achieve many of its scientific goals faster and with fewer resources.
  • The Salk Institute for Biological Studies was founded in the 1960s by Dr. Jonas Salk, the man responsible for creating the polio vaccine.
  • The institute features a team of internationally renowned and award-winning scientists who aim to explore life's very foundations.

Novelis Donates $10 Million to Children's Healthcare of Atlanta's "Never Settle: A Campaign for Kids"

Retrieved on: 
Thursday, December 8, 2022
Novelis, Copper, Campaign, Global e-Schools and Communities Initiative, Aditya Birla Group, Aluminium, Recycling, Patient, Paola Lattus, Research, Hospital, Riley Children's Foundation, Pediatrics, System, CHOA Arthur M. Blank Hospital, History, Multimedia, Polio, U.S. News & World Report, Rural development, Children's Healthcare of Atlanta, Metal, Pharmaceutical industry, Medicine, Child

From 2018 to 2020, Novelis employees sought out Children's more than 500 times for medical needs of their children.

Key Points: 
  • From 2018 to 2020, Novelis employees sought out Children's more than 500 times for medical needs of their children.
  • "This isa historic moment for Novelis to support a campaign with the potential to transform children's medical care in Georgia and beyond," said Novelis President and CEO Steve Fisher.
  • The centerpiece of the campaign is Arthur M. Blank Hospital, a 1.5 million-square-foot facility that is scheduled to open in fall 2024.
  • As the only freestanding pediatric healthcare system in Georgia, Children's Healthcare of Atlanta is the trusted leader in caring for kids.

Atmospheric Water Generators Integrated With IoT Are A Key Trend In The Atmospheric Water Generator Market - By The Business Research Company

Retrieved on: 
Tuesday, December 6, 2022
Water, Dysentery, Fever Dream, Global Citizen, Drinking water, Internet, Atmosphere, Cholera, Poverty, Diarrhea, Patient, AWG, Growth, Polio, WHO, Hepatitis A, Infection, Movement, World Health Organization, Silicon, Traction, Climate change, IOT, Risk

LONDON, Dec. 6, 2022 /PRNewswire/ -- The internet of things (IoT) integrated atmospheric water generators (AWG) is a key trend gaining traction in the atmospheric water generator market.

Key Points: 
  • LONDON, Dec. 6, 2022 /PRNewswire/ -- The internet of things (IoT) integrated atmospheric water generators (AWG) is a key trend gaining traction in the atmospheric water generator market.
  • Major companies operating in atmospheric water generator market are focusing on IoT and developing new products to strengthen their position in the market.
  • The increasing water scarcity will support the growth of the atmospheric water generator market .
  • As per the atmospheric water generator market research , lack of safe drinking water and sanitation will restrain the growth of the atmospheric water generator market.

Atmospheric Water Generators Integrated With IoT Are A Key Trend In The Atmospheric Water Generator Market - By The Business Research Company

Retrieved on: 
Tuesday, December 6, 2022
Water, Dysentery, Fever Dream, Global Citizen, Drinking water, Internet, Atmosphere, Cholera, Poverty, Diarrhea, Patient, AWG, Growth, Polio, WHO, Hepatitis A, Infection, Movement, World Health Organization, Silicon, Traction, Climate change, IOT, Risk

LONDON, Dec. 6, 2022 /PRNewswire/ -- The internet of things (IoT) integrated atmospheric water generators (AWG) is a key trend gaining traction in the atmospheric water generator market.

Key Points: 
  • LONDON, Dec. 6, 2022 /PRNewswire/ -- The internet of things (IoT) integrated atmospheric water generators (AWG) is a key trend gaining traction in the atmospheric water generator market.
  • Major companies operating in atmospheric water generator market are focusing on IoT and developing new products to strengthen their position in the market.
  • The increasing water scarcity will support the growth of the atmospheric water generator market .
  • As per the atmospheric water generator market research , lack of safe drinking water and sanitation will restrain the growth of the atmospheric water generator market.

Travel Vaccine Global Market Report 2022: Stringent Advisories and Regulations by Health Authorities to Aid Growth - ResearchAndMarkets.com

Retrieved on: 
Thursday, December 1, 2022
Other Travel, Pharmaceutical, Health, Travel, Sissel v. United States Department of Health & Human Services, COVID-19, Growth, Rotavirus, Typhoid fever, International Certificate of Vaccination or Prophylaxis, Human services, National Health Service, Health, Vaccine, Infection, Tetanus, Hepatitis B, Antibody, Hepatitis A, Fever Dream, Shingles, Tourism, Yellow fever, Travel, Cholera, Meningitis, Diphtheria, Disease, Spiritualism, Vaccination, Rubella, Mumps, Measles, Polio, Composition, Chickenpox, NHS, DPT, Rabies

The global travel vaccine market is anticipated to grow at a steady rate in the forecast period, 2023-2027.

Key Points: 
  • The global travel vaccine market is anticipated to grow at a steady rate in the forecast period, 2023-2027.
  • The market growth can be attributed to the rising incidences of flu and rapid growth in the travel and tourism sector.
  • Travel vaccines, also known as travel immunizations, are vaccine shots that protect travelers from serious illnesses.
  • Increasing regulations for safe traveling are supporting the normalization of travel vaccines among travelers, which is expected to boost the market growth.

PharmaJet Receives NIH Grant to Evaluate use of Needle-free Intradermal Delivery for HPV Immunization

Retrieved on: 
Tuesday, November 29, 2022
Research, Medical Devices, Medical Supplies, Clinical Trials, Biotechnology, Health, Pharmaceutical, Science, Oncology, Cervical cancer, Tropy, Use, Padjadjaran University, UNPAD, N/S, National Cancer Institute, Health, Regulatory affairs, Research, Injection, Death, ID, Cancer, Radiation, NIH, HPV, Ageing, Polio, Woman, Vaccine

The study will compare Tropis intradermal delivery against traditional needle and syringe (N/S) intramuscular administration.

Key Points: 
  • The study will compare Tropis intradermal delivery against traditional needle and syringe (N/S) intramuscular administration.
  • The study, in collaboration with Padjadjaran University (UNPAD) in Indonesia, will begin recruiting approximately 900 girls, aged 9 to 14 years of age in early 2023.
  • This follows PharmaJets preliminary studies evaluating intradermal delivery for HPV vaccines.1 Intradermal administration is already widely used for polio vaccine delivery and has been found to be safe, effective, and immunogenic.
  • Intradermal administration of vaccines can provide benefits for low resource settings including lower costs, increased coverage, and increased acceptability.

PharmaJet Needle-free System Selected to Deliver Intradermal Polio Vaccine in Nigerian Campaign

Retrieved on: 
Tuesday, November 8, 2022
Health, Medical Supplies, Medical Devices, CE marking, United Nations, Review, Global Polio Eradication Initiative, U.S. FDA, LGA, World Health Organization, Injection, Sias, GPEI, Vaccine, Certification, Stockholm Environment Institute US Center, Gavi, Centers for Disease Control and Prevention, UNICEF, Public health, OPV, PQS, Polio, World, Use, Partnership, Bill & Melinda Gates Foundation, IPV, System, CDC, Rotary International, Multimedia, Research, Paralysis, WHO, CEO

View the full release here: https://www.businesswire.com/news/home/20221108005025/en/

Key Points: 
  • View the full release here: https://www.businesswire.com/news/home/20221108005025/en/
    Kangethe Ngure, Regional Director for Africa, PharmaJet, demonstrating Tropis device use to trainers in Sokoto, Nigeria.
  • The Nigeria pilot campaign will combine the nOPV2 oral vaccine with an intradermal polio vaccine (1/5 of a full IPV dose) administered with the PharmaJet Tropis NFIS.
  • We are pleased to be selected for the polio vaccine campaign in Nigeria to curtail the spread of cVDPV2, said Chris Cappello, President and CEO of PharmaJet.
  • Intradermal administration of polio vaccine with the PharmaJet Tropis NFIS has already been successfully used in mass vaccination campaigns in Somalia, Pakistan, Cuba, and The Gambia.

SINOVAC Varicella Vaccine Prequalified by WHO

Retrieved on: 
Friday, November 4, 2022
Health, Infectious Diseases, COVID-19, Clinical Trials, Pharmaceutical, Biotechnology, Company, Mumps, Polio, III, World, Influenza A virus subtype H1N1, World Health Organization, WHO, Foot-and-mouth disease virus, Hepatitis A, Vaccine, COVID-19, H5N1, CEO, National TB Elimination Program (India), Chickenpox, Seroconversion, HFMD, Oka, NASDAQ, Infection, R, Streptococcus, EV71, Program, Sinovac Biotech

This marks the first WHO prequalified Chinese varicella vaccine and the fourth SINOVAC vaccine to receive WHO approval.

Key Points: 
  • This marks the first WHO prequalified Chinese varicella vaccine and the fourth SINOVAC vaccine to receive WHO approval.
  • Mr. Weidong Yin, Chairman, President and CEO of Sinovac, commented, Now that SINOVAC has received WHO prequalification for our varicella vaccine, we can provide a new weapon for prevention and control of infectious diseases globally.
  • Previously, three other vaccines by SINOVAC were also approved by WHO in various uses and conditions, including Healive (the hepatitis A vaccine), CoronaVac (the COVID-19 vaccine) and the Sabin-strain inactivated polio vaccine.
  • In 2022, SINOVACs Sabin-strain inactivated polio vaccine (sIPV) and varicella vaccine were prequalified by the WHO.

SINOVAC to Showcase Products at CPHI Frankfurt

Retrieved on: 
Friday, October 28, 2022
Science, Other Science, Biotechnology, Research, Pharmaceutical, General Health, Health, Infectious Diseases, R, Chickenpox, Company, Influenza A virus subtype H1N1, Mumps, NASDAQ, Polio, H5N1, Vaccine, Pyaar Tune Kya Kiya (TV series), Foot-and-mouth disease virus, Booth, EV71, Streptococcus, Program, COVID-19, Infection, HFMD, Hepatitis A, WHO, Sinovac Biotech, Fine chemical

Sinovac Biotech Ltd. (SINOVAC or the Company) (NASDAQ: SVA), a leading provider of biopharmaceutical products in China, announced that the Company will participate in CPHI Frankfurt, one of the worlds largest pharmaceutical exhibitions, from 1st to 3rd of November, in Frankfurt, Germany.

Key Points: 
  • Sinovac Biotech Ltd. (SINOVAC or the Company) (NASDAQ: SVA), a leading provider of biopharmaceutical products in China, announced that the Company will participate in CPHI Frankfurt, one of the worlds largest pharmaceutical exhibitions, from 1st to 3rd of November, in Frankfurt, Germany.
  • At Booth#41G20, the first floor of Hall 4, Messe Frankfurt, SINOVAC will greet all visitors of CPHI and present its comprehensive portfolio.
  • Helen Yang, Chief Business Officer of SINOVAC said, SINOVAC is an old friend of CPHI, and we are happy to finally return to CPHIs in-person event for the first time since the outbreak of the COVID-19 pandemic globally.
  • SINOVAC continually dedicates itself to new vaccine R&D, with more combination vaccine products in its pipeline, and constantly explores global market opportunities.

Global Electric Wheelchair Market Research Report (2022 to 2028) - Featuring Karman Healthcare, Kwang Yang Motor, Levo USA and Magic Mobility Among Others - ResearchAndMarkets.com

Retrieved on: 
Monday, October 17, 2022
Other Manufacturing, Manufacturing, Adoption, News, Leg, Transport, Growth, Population, CAGR, Hospital, Wheelchair Foundation, WHO, World, Accident, COVID-19, Locomotion, Polio, World Health Organization, Hepatitis C, Wheelchair, Arthralgia, Taxicab, Marketing

The "Global Electric Wheelchair Market Research and Forecast, 2022-2028" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Global Electric Wheelchair Market Research and Forecast, 2022-2028" report has been added to ResearchAndMarkets.com's offering.
  • The global electric wheelchair market is anticipated to grow at a CAGR of around 9.2% during the forecast period 2021-2027.
  • For instance, joint pain causes by arthritis limits leg and lower body mobility, resulting in locomotion restrictions.
  • On the contrary, the increasing adoption of prosthetics is one of the major factors hindering the growth of the market.